Label: EQUATE MUCUS D- guaifenesin and pseudoephedrine hydrochloride tablet, multilayer, extended release
- NDC Code(s): 79903-125-18, 79903-125-36
- Packager: WALMART INC.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated October 19, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredients (in each extended-release bi-layer tablet)
- Purposes
-
Uses
- •
- helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
- •
- temporarily relieves nasal congestion due to:
- •
- common cold
- •
- hay fever
- •
- upper respiratory allergies
- •
- temporarily restores freer breathing through the nose
- •
- promotes nasal and/or sinus drainage
- •
- temporarily relieves sinus congestion and pressure
-
Warnings
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- •
- heart disease
- •
- high blood pressure
- •
- thyroid disease
- •
- diabetes
- •
- trouble urinating due to an enlarged prostate gland
- •
- persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
- •
- cough accompanied by too much phlegm (mucus)
- Directions
- Other information
- Inactive ingredients
- Questions or comments?
-
Package/Label Principal Display Panel
equate™
Compare to Mucinex® D active ingredients
Mucus-D
Guaifenesin 600 mg/Pseudoephedrine Hydrochloride 60 mg
12 HOUR
Extended-Release Bi-Layer Tablets
Expectorant/Nasal Decongestant
• Clears nasal/sinus congestion
• Thins and loosens mucus
• Immediate and extended release
Actual Size
18 EXTENDED-RELEASE BI-LAYER TABLETS
-
INGREDIENTS AND APPEARANCE
EQUATE MUCUS D
guaifenesin and pseudoephedrine hydrochloride tablet, multilayer, extended releaseProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:79903-125 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN 600 mg PSEUDOEPHEDRINE HYDROCHLORIDE (UNII: 6V9V2RYJ8N) (PSEUDOEPHEDRINE - UNII:7CUC9DDI9F) PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg Inactive Ingredients Ingredient Name Strength CARBOMER HOMOPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: HHT01ZNK31) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) Product Characteristics Color ORANGE Score no score Shape OVAL Size 17mm Flavor Imprint Code L6 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:79903-125-18 1 in 1 CARTON 10/01/2022 1 18 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:79903-125-36 2 in 1 CARTON 10/01/2022 2 18 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA214407 10/01/2022 Labeler - WALMART INC. (051957769)